Jiyuan Yan Selected Research

Therapeutics

12/2019	Electromagnetic field treatment increases purinergic receptor P2X7 expression and activates its downstream Akt/GSK3β/β-catenin axis in mesenchymal stem cells under osteogenic induction.
1/2019	Schisandrin A Inhibits the IL-1β-Induced Inflammation and Cartilage Degradation via Suppression of MAPK and NF-κB Signal Pathways in Rat Chondrocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiyuan Yan Research Topics

Disease

4	Osteoarthritis 09/2023 - 01/2021
2	Inflammation (Inflammations) 09/2019 - 01/2019
1	Compression Fractures (Compression Fracture) 03/2024
1	Intervertebral Disc Degeneration 11/2023
1	Gout 07/2023
1	Rheumatoid Arthritis 07/2023
1	Asthma (Bronchial Asthma) 07/2023
1	Ankylosing Spondylitis 07/2023
1	Postoperative Pain 08/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Osteoporosis 12/2019

Drug/Important Bio-Agent (IBA)

1	Bone Cements (Bone Glue)IBA 03/2024
1	Indicators and Reagents (Reagents)IBA 11/2023
1	tizoxanideIBA 09/2023
1	Coenzyme A (CoA)IBA 07/2023
1	GelatinIBA 08/2021
1	Ropivacaine (Naropin)FDA LinkGeneric 08/2021
1	breviscapineIBA 01/2021
1	selonsertibIBA 01/2021
1	rhoifolinIBA 01/2021
1	FlavonoidsIBA 01/2021
1	liquiritigeninIBA 09/2019
1	LigninIBA 01/2019
1	schizandrin AIBA 01/2019

Therapy/Procedure

2	Therapeutics 12/2019 - 01/2019
1	Kyphoplasty 03/2024
1	Length of Stay 08/2021